Dataset Information

Most cancer cell lines give very modest transcriptional regulation following treatment with the SUMO activating enzyme inhibitors TAK-981 or ML-792

ABSTRACT: Most cancer cell lines give very modest transcriptional regulation following treatment with the SUMO activating enzyme inhibitors TAK-981 or ML-792

PROVIDER: PRJNA723843 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	SRR14301732_1.fastq.gz	Fastqsanger.gz
	SRR14301732_2.fastq.gz	Fastqsanger.gz
	SRR14301733_1.fastq.gz	Fastqsanger.gz
	SRR14301733_2.fastq.gz	Fastqsanger.gz
	SRR14301734_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 114

Dataset Information

Most cancer cell lines give very modest transcriptional regulation following treatment with the SUMO activating enzyme inhibitors TAK-981 or ML-792

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets